No Data
No Data
Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
NAYA Biosciences: Announces Strategic Decision to Separate Fertility and Oncology Businesses Into Distinct Ops, Renamed 'INVO Fertility, Inc.'
NAYA Biosciences: Private Co to Operate as NAYA Therapeutics and Focus on Clinical Development of Bifunctional Antibodies >NAYA
Press Release: NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses Into Distinct Operations -- Company Renamed "INVO Fertility, Inc."
Express News | Naya Biosciences Inc : Maxim Group Cuts Target Price to $6 From $24
NAYA Biosciences Delays 2024 Yearly Report Filing